Open Access

Erratum to: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis

  • B Douglas Smith1,
  • Charles L Beach2,
  • Dalia Mahmoud3,
  • Laura Weber3 and
  • Henry J Henk4Email author
Contributed equally
Experimental Hematology & Oncology20143:19

DOI: 10.1186/2162-3619-3-19

Received: 3 July 2014

Accepted: 16 July 2014

Published: 16 July 2014

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.

After the publication of this work [1], it was brought to our attention that a statement in the article is not consistent with the data. The statement “Prior RBC transfusions were found to significantly increase the time to hospitalization (adjusted HR 1.373, p = 0.018) while no other covariates examined were found to impact the risk of hospitalization” is not a correct reflection of the results from the data analysis in Table 2 of the article.

The corrected statement is provided here as follows:

“Prior RBC transfusions were found to significantly shorten the time to hospitalization (adjusted HR 1.373, p = 0.018) while no other covariates examined were found to impact the risk of hospitalization.”

Notes

Authors’ Affiliations

(1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
(2)
Hematology/Oncology Clinical Research and Development, Celgene
(3)
Global Pricing and Market Access, Celgene
(4)
Health Economic and Outcomes Research, Optum

References

  1. Smith DB, Beach CL, Mahmoud D, Weber L, Henk HJ: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol 2014, 3: 10. 10.1186/2162-3619-3-10PubMed CentralPubMedView ArticleGoogle Scholar

Copyright

© Smith et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement